Gilead Sciences, Inc. [GILD] Insider Parsey Merdad sells 8,230 Shares – Latest Insider Activity
In a filing, Gilead Sciences, Inc. revealed its Chief Medical Officer Parsey Merdad unloaded Company’s shares for reported $0.6 million on Feb 29 ’24. In the deal valued at $72.74 per share,8,230 shares were sold. As a result of this transaction, Parsey Merdad now holds 92,706 shares worth roughly $6.73 million. Then, Parsey Merdad sold […]
Taking a look at what insiders are doing to gauge the Gilead Sciences, Inc. (GILD)’s direction
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Gilead Sciences, Inc. shares valued at $598,624 were sold by Parsey Merdad on Feb 29 ’24. At $72.74 per share, Parsey Merdad sold 8,230 shares. The insider’s holdings dropped to 92,706 […]
Taking a Closer Look At Gilead Sciences, Inc. (GILD) Following Its Recent Trade
Gilead Sciences, Inc.’s filing revealed that its Chief Medical Officer Parsey Merdad unloaded Company’s shares for reported $0.6 million on Feb 29 ’24. In the deal valued at $72.74 per share,8,230 shares were sold. As a result of this transaction, Parsey Merdad now holds 92,706 shares worth roughly $6.79 million. Then, Parsey Merdad sold 2,000 […]
Sharp increase in GILD’s short interest leads to surge in days-to-cover ratio
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Gilead Sciences, Inc. shares valued at $598,624 were sold by Parsey Merdad on Feb 29 ’24. At $72.74 per share, Parsey Merdad sold 8,230 shares. The insider’s holdings dropped to 92,706 […]
Gilead Sciences, Inc. [GILD] Insider Activity: An Update for Investors
Gilead Sciences, Inc.’s recently made public that its Chief Medical Officer Parsey Merdad unloaded Company’s shares for reported $0.6 million on Feb 29 ’24. In the deal valued at $72.74 per share,8,230 shares were sold. As a result of this transaction, Parsey Merdad now holds 92,706 shares worth roughly $6.96 million. Then, Parsey Merdad sold […]
Gilead Sciences, Inc. [NASDAQ: GILD] Sees Decrease in Stock Value
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Gilead Sciences, Inc. shares valued at $598,624 were sold by Parsey Merdad on Feb 29 ’24. At $72.74 per share, Parsey Merdad sold 8,230 shares. The insider’s holdings dropped to 92,706 shares worth approximately […]
Gilead Sciences, Inc. (GILD) may enjoy gains as insiders got busy in the recent days
Gilead Sciences, Inc.’s recent filing unveils that its Chief Medical Officer Parsey Merdad unloaded Company’s shares for reported $0.6 million on Feb 29. In the deal valued at $72.74 per share,8,230 shares were sold. As a result of this transaction, Parsey Merdad now holds 92,706 shares worth roughly $6.7 million. Then, Parsey Merdad sold 2,000 […]
Gilead Sciences, Inc. [GILD] 10% Owner makes an insider purchase of 910,000 shares worth 20.02 million.
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Gilead Sciences, Inc. shares valued at $20,020,000 were purchased by GILEAD SCIENCES, INC. on Feb 12. At $22.00 per share, GILEAD SCIENCES, INC. acquired 910,000 shares. The insider’s holdings grew to 4,126,119 shares worth […]
Gilead Sciences, Inc. (GILD) rating downgrades by Truist
Gilead Sciences, Inc.’s filing revealed that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million on Feb 12. In the deal valued at $22.00 per share,910,000 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 4,126,119 shares worth roughly $303.48 million. Then, GILEAD SCIENCES, INC. bought […]
Investing in Gilead Sciences, Inc. (GILD): What You Must Know
Gilead Sciences, Inc.’s filing revealed that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million on Feb 12. In the deal valued at $22.00 per share,910,000 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 4,126,119 shares worth roughly $297.25 million. Then, GILEAD SCIENCES, INC. bought […]